There are 11 resources available
ESMO Magnitude of Clinical Benefit Scale
Presenter: R. Kanesvaran, SG
Session: SESSION 4 Metastatic prostate cancer
Resources:
Metastatic CRPC: Standard of care in 2019
Presenter: A. Azad, AU
Session: SESSION 4 Metastatic prostate cancer
Resources:
Metastatic CRPC: What’s on the horizon – new treatments
Presenter: K. Fizazi, FR
Session: SESSION 4 Metastatic prostate cancer
Resources:
Oligometastatic prostate cancer
Presenter: M. L. K. Chua, SG
Session: SESSION 3 Intermediate situation of advanced prostate cancer
Resources:
M0 Castrate Resistant Prostate Cancer (CRPC): What are our latest options?
Presenter: A. Azad, AU
Session: SESSION 3 Intermediate situation of advanced prostate cancer
Resources:
Metastatic hormone sensitive prostate cancer: State of the art management in 2019
Presenter: R. Kanesvaran, SG
Session: SESSION 4 Metastatic prostate cancer
Resources:
Role of radiotherapy: Recent advances in RT modalities
Presenter: M. L. K.Chua, SG
Session: SESSION 2 High risk localized prostate cancer
Resources:
High risk localized disease: Integrating drugs with local treatments
Presenter: D. M. C. Poon, HK
Session: SESSION 2 High risk localized prostate cancer
Resources:
Rising PSA: What to do?
Presenter: D. M. C. Poon, HK
Session: SESSION 3 Intermediate situation of advanced prostate cancer
Resources:
Welcome and Course Overview
Presenter: K. Fizazi, FR R. Kanesvaran, SG
Session: Welcome and Course Overview
Resources: